U.S. based EndoGastric Solutions® has received a significant round of funding from investors including Vertex Growth Fund, to further accelerate commercialization efforts in support of the growing market demand for its Transoral Incisionless Fundoplication (TIF® 2.0) procedure performed with the EsophyX® device.
Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announced today publication of two-year follow-up data from its randomized, sham-controlled, double-blinded trial (AIRFLOW-2) that confirms long-term safety and durable effect of Targeted Lung Denervation (TLD) therapy in COPD patients.
Nuvaira's proprietary TLD technology has demonstrated safety and feasibility in three completed clinical studies, and physician and patient interest in the therapy has enabled continued enrollment in Nuvaira's FDA pivotal trial (AIRFLOW-3).
After reporting over 400% year over year revenue growth, Verbit is excited to announce it has raised an additional USD 60M Series C round. The round is led by Sapphire Ventures, with participation from existing investors Vertex Ventures, Stripes, HV Ventures and ClalTech, as well as new investor Vertex Growth.
How Taranis is soaring above the rest with its high-resolution field images
In a remote corner of Sumatra Island in Indonesia lies one of the largest sugarcane farms in Asia. At 35,000 hectares, it is almost half of Singapore and contributes to a substantial amount of domestic sugar consumption in Indonesia, with some of the highest production yields in the region.
Introducing Validus Capital, a member of the Vertex Growth and Vertex SEA and India family.
A well-established major financial centre, Singapore is now a global nexus between the East and West, and is the preferred destination for many major corporations worldwide to set up their regional headquarters in Southeast Asia. But did you know that 99% of companies in Singapore are actually small and medium enterprises (SMEs)?
Validus Capital has joined the Singapore banks in offering government-backed loans under Enterprise Singapore's Enterprise Financing Scheme. The Singapore-based fintech this week secured official approval to offer small and medium-sized enterprises (SMEs) financing that has up to 90 per cent of the risk taken up by the government.